SCD and inflammatory bowel disease: WOL treatment downregulated the colonic expression of Il6, leading to a decrease in cytokines delivered to the liver, thereby resulting in the upregulation of Scd1 and preventing the onset of an early event prior to IBD clinical symptoms.